glp 1 microdose tirzepatide Microdosing Microdosing GLP-1: Should You Try

Liraglutide (NN2211) is a long-acting GLP-1 receptor agonist used to treat type 2 diabetes and obesity (Victoza, Saxenda)

Promotes fat loss and body recomposition

Explore the study delving into GLP-1 RA medications adherence among diabetes patients

But then again anticipating what's next is something we've been doing for 65 years

The ProRx warning letter signals increased FDA scrutiny of compounded weight loss product that are not intended to be compounded in the US.

GLP-1 receptor agonists like semaglutide originally developed for diabetes and obesity also exhibit antidepressant properties, highlighting their dual therapeutic promise